Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 482,374 | 1,074,036 | 716,782 | 532,756 | 487,429 |
Marketable Securities | 298,073 | 74,244 | N/A | N/A | N/A |
Receivables | 41,189 | 29,713 | 24,351 | 16,562 | 19,232 |
Inventories | 83,248 | 69,922 | 67,009 | 49,592 | 28,313 |
TOTAL | $929,063 | $1,273,383 | $837,040 | $622,892 | $555,194 |
Non-Current Assets | |||||
PPE Net | 65,384 | 56,491 | 52,955 | 53,953 | 60,180 |
Investments And Advances | 0 | 0 | 50,043 | 0 | 0 |
Intangibles | 199,814 | 204,866 | 209,919 | 49,261 | 53,682 |
Other Non-Current Assets | 135,576 | 121,695 | 93,551 | 70,049 | 73,243 |
TOTAL | $400,774 | $383,052 | $406,468 | $173,263 | $187,105 |
Total Assets | $1,329,837 | $1,656,435 | $1,243,508 | $796,155 | $742,299 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 214,987 | 182,117 | 125,030 | 42,853 | 13,184 |
Accrued Expenses | N/A | N/A | N/A | 63,398 | 59,515 |
Other current liabilities | N/A | N/A | N/A | N/A | 280 |
TOTAL | $225,629 | $190,243 | $135,166 | $118,807 | $85,240 |
Non-Current Liabilities | |||||
Long Term Debt | 1,155,313 | 1,125,250 | 566,588 | 356,318 | 335,940 |
Other Non-Current Liabilities | 253,792 | 223,355 | 117,183 | 30,433 | 39,916 |
TOTAL | $1,436,131 | $1,378,241 | $697,874 | $401,464 | $395,385 |
Total Liabilities | $1,661,760 | $1,568,484 | $833,040 | $520,271 | $480,625 |
Shareholders' Equity | |||||
Shares Outstanding, K | 148,492 | 136,405 | 118,905 | 103,043 | 89,776 |
Common Shares | 1,480 | 1,357 | 1,187 | 1,028 | 897 |
Retained earnings | -3,446,145 | -2,696,578 | -2,265,243 | -1,830,589 | -1,536,499 |
Other shareholders' equity | -745 | 756 | 968 | 193 | -10 |
TOTAL | $-331,923 | $87,951 | $410,468 | $275,884 | $261,674 |
Total Liabilities And Equity | $1,329,837 | $1,656,435 | $1,243,508 | $796,155 | $742,299 |